NASDAQ: ENGN
Engene Therapeutics Inc Earnings Dates, Reports, Calls

Engene Therapeutics earnings were -$130.4M for the trailing 12 months ending Jul 31, 2026, with N/A growth year over year. The latest ENGN earnings report on Jul 31, 2026 announced Q3 2026 earnings of -$32.5M, up 7.5% from last quarter. For the last reported fiscal year 2025 ending Oct 31, 2025, ENGN reported annual earnings of -$117.3M, with 112.7% growth. The next ENGN earnings date is Dec 28, 2026.

ENGN earnings history

Current Revenue
$0.0
Current Earnings
-$130.4M
Current Profit Margin
0%

ENGN Return on Equity

Current Company
-55.8%
Current Industry
-10.8%
Current Market
30.9%
ENGN's Return on Equity (-55.8%)... subscribe to Premium to read more.
High Return on Equity Performance

ENGN Return on Assets

Current Company
-45.2%
Current Industry
-10.7%
ENGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ENGN announces earnings.

ENGN Return on Capital Employed

Current Company
-48.94%
Current Industry
-7.4%
ENGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ENGN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ENGN-$126.10M-$130.36MN/A-$2.07
IMUX-$127.39M-$128.30MN/A-$3.57
AKBA-$26.81M-$44.56MN/A-$0.16
SPRB-$62.26M-$67.15MN/A-$33.71
RTSNN/AN/AN/AN/A

ENGN earnings dates

Next earnings date
Dec 28, 2026

Engene Therapeutics Earnings Reports & History FAQ

What were Engene Therapeutics's earnings last quarter?

Engene Therapeutics (NASDAQ: ENGN) reported Q2 2026 earnings per share (EPS) of -$0.47, up 17.54% year over year. Total ENGN earnings for the quarter were -$32.50 million. In the same quarter last year, Engene Therapeutics's earnings per share (EPS) was -$0.57.

If you're new to stock investing, here's how to buy Engene Therapeutics stock.

When does Engene Therapeutics report earnings?

The next ENGN earnings date is Dec 28, 2026. Add ENGN to your watchlist to be reminded of Engene Therapeutics's next earnings date.

Is Engene Therapeutics profitable or losing money?

As of the last Engene Therapeutics earnings report, Engene Therapeutics is currently losing money. Engene Therapeutics's net profit (also called net income) for the twelve months ending Jul 31, 2026 was -$130.36 million, a 37.63% increase year over year.

What was ENGN's earnings growth in the past year?

As of Engene Therapeutics's earnings date in Q4 2026, Engene Therapeutics's earnings has grown year over year. ENGN earnings in the past year totalled -$130.36 million.

What are Engene Therapeutics's earnings expectations?

The current EPS estimate for Engene Therapeutics's earnings report in Dec 28, 2026 is -$0.48.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.